Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal Carcinoma

NCT07645846 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Sinonasal Carcinoma

Interventions

DRUG: Neoadjuvant Chemo-Immunotherapy

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]